These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 16230042

  • 1. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
    Höybye C, Hilding A, Marcus C, Thorén M.
    Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
    [Abstract] [Full Text] [Related]

  • 2. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C, Thorén M, Böhm B.
    J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
    [Abstract] [Full Text] [Related]

  • 3. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.
    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C.
    Growth Horm IGF Res; 2010 Jun; 20(3):179-84. PubMed ID: 20199883
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 5. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE, Carrel AL, Whitman BY, Allen DB.
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.
    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C.
    Growth Horm IGF Res; 2011 Aug; 21(4):185-90. PubMed ID: 21664161
    [Abstract] [Full Text] [Related]

  • 7. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A, Di Giorgio G, Manco M, Grugni G, Maggioni A.
    Horm Res; 2007 Aug; 68(2):83-90. PubMed ID: 17337902
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 11. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C, Rigamonti AE, Giannone G, Berardinelli R, Cella SG, Cappa M, Müller EE.
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [Abstract] [Full Text] [Related]

  • 12. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
    Bosio L, Beccaria L, Benzi F, Sanzari A, Chiumello G.
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC, Lindberg A.
    Horm Res; 2008 Apr; 70(3):182-7. PubMed ID: 18663319
    [Abstract] [Full Text] [Related]

  • 14. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C.
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
    Höybye C, Hilding A, Jacobsson H, Thorén M.
    Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR, Lee PD, Whitman BY, Zipf WB, Frey M, Myers S, Cahan M, Pinyerd B, Southren AL.
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
    [Abstract] [Full Text] [Related]

  • 17. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
    Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
    [Abstract] [Full Text] [Related]

  • 18. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
    Höybye C.
    Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
    [Abstract] [Full Text] [Related]

  • 19. Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study.
    Jørgensen AP, Ueland T, Sode-Carlsen R, Schreiner T, Rabben KF, Farholt S, Høybye C, Christiansen JS, Bollerslev J.
    Growth Horm IGF Res; 2014 Feb; 24(1):16-21. PubMed ID: 24360789
    [Abstract] [Full Text] [Related]

  • 20. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG, Boroujerdi MA, Powrie J, Dall R, Napoli R, Ehrnborg C, Pentecost C, Cittadini A, Jørgensen JO, Sonksen PH, GH-2000 Study Group.
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.